2026-04-14T08:33:51Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1900022025-12-05T16:32:50Zcom_2072_1057col_2072_478916col_2072_478917col_2072_478921

Type 2 diabetes mellitus and COVID-19: a narrative review Rey Reñones, Cristina Martinez Torres, Sara Martín Luján, Francisco M Pericas, Carles Redondo, Ana Vilaplana Carnerero, Carles Domínguez García, Àngela Grau, Maria Diabetis COVID-19 Epidemiologia Diabetes COVID-19 Epidemiology Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients. 2022-10-19T14:32:53Z 2022-10-19T14:32:53Z 2022-08-26 2022-10-19T14:32:53Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2227-9059 https://hdl.handle.net/2445/190002 724610 36140191 eng Reproducció del document publicat a: Biomedicines, 2022, vol. 10, p. 2089 cc-by (c) Rey Reñones, Cristina et al., 2022 https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess 12 p. application/pdf MDPI Articles publicats en revistes (Medicina)